NTRS
35
-5
SBUX
32
-4
FLR
46
-3
AVGO
88
-5
ORCL
50
-2
DE
55
2
ESS
53
-4
CI
30
-2
KR
52
-3
BA
68
-2
PG
43
-3
ETN
67
-4
GD
39
-3
FE
32
-2
HP
48
-5
BAX
41
2
CCI
31
6
MCD
55
-4
AAL
51
-6
HPQ
53
-3
NTRS
35
-5
SBUX
32
-4
FLR
46
-3
AVGO
88
-5
ORCL
50
-2
DE
55
2
ESS
53
-4
CI
30
-2
KR
52
-3
BA
68
-2
PG
43
-3
ETN
67
-4
GD
39
-3
FE
32
-2
HP
48
-5
BAX
41
2
CCI
31
6
MCD
55
-4
AAL
51
-6
HPQ
53
-3
Financhill
Back

Sage Therapeutics Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
32

SAGE
Sage Therapeutics

Last Price:
5.03
Seasonality Move:
3.43%

7 Day Trial

ALL ACCESS PASS

$ 7

These 7 Stocks Will Be Magnificent in 2025

Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.

Sage Therapeutics Stock Forecast

  • Over the next 52 weeks, Sage Therapeutics has on average historically risen by 2.7% based on the past 10 years of stock performance.
  • Sage Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
  • Is Sage Therapeutics Stock Undervalued?
    The current Sage Therapeutics [SAGE] share price is $5.27. The Score for SAGE is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • SAGE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Sage Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sage Therapeutics has on average historically risen by 2.7% based on the past 10 years of stock performance.

Sage Therapeutics Stock Rating

Sell
32
Sage Therapeutics (SAGE) is a Sell

Is Sage Therapeutics overpriced?

  • Sage Therapeutics has risen higher in 4 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%

Sage Therapeutics Stock Price History

Is SAGE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAGE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sagerx.com

52-Week Data

52-Week High:
28.26
52-Week Low:
4.62

Prediction Charts

Market Cap:
322.38M
Price in USD:
5.27
Volume:
1.17M
Beta:
1.32

Technical Analysis

SMA50:
6.16
SMA100:
7.14
SMA200:
10.55
52-Wk Change:
-75.67%

Stock Predictions

  • Is Sage Therapeutics stock public?
    Yes, Sage Therapeutics is a publicly traded company.
  • What is the Sage Therapeutics stock quote today?
    The Sage Therapeutics stock price is 5.27 USD today.
  • How to buy Sage Therapeutics stock online?
    You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-27 5.78 5.55 5.91 5.48
Nov-29 5.50 5.47 5.59 5.42
Dec-2 5.47 5.79 5.83 5.45
Dec-3 5.78 5.60 5.78 5.53
Dec-4 5.67 5.61 5.79 5.58
Dec-5 5.52 5.60 5.82 5.52
Dec-6 5.60 5.61 5.81 5.50
Dec-9 5.68 5.56 5.80 5.54
Dec-10 5.50 5.57 5.69 5.42
Dec-11 5.61 5.89 5.91 5.51
Dec-12 5.73 5.67 5.76 5.54
Dec-13 5.66 5.39 5.72 5.03
Dec-16 5.32 5.35 5.54 5.17
Dec-17 5.29 5.27 5.48 5.07

Sage Therapeutics Earnings

Sage Therapeutics Earnings Report: Per Share Sage Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sage Therapeutics Forecast Revenue Growth

Sage Therapeutics Stock Analysis: Historical quarterly revenues per share for Sage Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.06 per share, and an increase next year of $2.71 per share.

* Sage Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.